Integral Biosystems logo — Pharmaceutical Drug Development, CRO, Ophthalmic Drug Delive...

Integral Biosystems

Pharmaceutical Drug Development, CRO, Ophthalmic Drug Delivery, Injectables, Microspheres, Sustained Release

Founded 2011 United States Bedford, United States 11 employees

General Information

Company Name Integral Biosystems
Founded Year 2011
Location United States Bedford, United States +1
Employees 11
Social

Get notified when Integral Biosystems moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Integral Biosystems

Integral BioSystems, established in 2011 and headquartered in Bedford, Massachusetts, is a prominent contract research organization specializing in pharmaceutical drug development and related services. With a sprawling 10,000 square foot facility, the company excels in creating complex formulations and dosage forms for various applications, including ophthalmic, dermal, injectable, otic, pulmonary, intranasal, and rectal dose forms. Their expertise extends to sustained release drug development, featuring technologies like injectable microspheres, liposomes, hydrogels, nano-complexes, and micro/nanocrystals. Integral BioSystems' services encompass formulation development, analytical method development, scale-up/technology transfer, and licensable technologies for enhanced drug delivery. Their team's extensive experience in drug formulation and development, complemented by a remarkable track record of success, sets them apart in the industry. The company is dedicated to advancing drug delivery through cutting-edge research and development, establishing itself as a trusted partner in pharmaceutical development. Integral BioSystems' profound impact on the pharmaceutical industry is evidenced by their credibility and significant track record. Their mission to facilitate the seamless transition of research concepts to clinic-ready products, coupled with their commitment to innovation, quality, and client satisfaction, positions them as industry leaders. Underpinning these efforts is a team of highly skilled professionals dedicated to driving innovation in pharmaceutical drug development and delivery.

Taxonomy: Pharmaceutical Drug Development, CRO, Ophthalmic Drug Delivery, Injectables, Microspheres, Sustained Release, Formulation Development, Analytical Method Development, Scale-Up/Technology Transfer, Licensable Technologies, Innovation, Drug Delivery Experts, Nanocrystals Development, Protein/Peptide/RNAi/DNA Delivery

No funding data available for Integral Biosystems yet.

Get notified when Integral Biosystems raises funding

Integral Biosystems Alternatives & Competitors

Integral Biosystems vs

Delivering Precision in Pharmaceutical Sciences Through Innovative Drug Development

Seed
Biotechnology, Pharmaceutical
Integral Biosystems vs
Nanoform
Nanoform Finland

Nanoform uses platform technologies to develop innovative nanoparticle medicines, reducing clinical...

Grant
Biotechnology, Pharmaceutical
Integral Biosystems vs

We CARE. We CREATE. We DELIVER.

Grant
326 employees
Biotechnology, Health Care

FAQ About Integral Biosystems

Pharmaceutical Drug Development, CRO, Ophthalmic Drug Delivery, Injectables, Microspheres, Sustained Release
Integral Biosystems was founded in 2011.
Integral Biosystems is headquartered in Bedford, United States.
Integral Biosystems has approximately 11 employees.
Top alternatives and competitors to Integral Biosystems include Molecular Formulations, Nanoform, LTS Lohmann Therapie-Systeme AG, Bionex Pharmaceuticals LLC, Apidel. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Integral Biosystems and Molecular Formulations are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Integral Biosystems and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy